H. Lundbeck A/S is to acquire Longboard Pharmaceuticals Inc. in an all-cash deal valuing the epilepsy specialist at $2.6 billion. The agreed price of $60 per share is a 54% premium to the closing ...
Longboard Pharmaceuticals has displayed a staggering YTD performance of +875.79%, significantly outpacing the S&P 500’s +22.85%. This impressive rise highlights not just the company’s operational ...
Lundbeck agreed to acquire Longboard Pharmaceuticals in a transaction valued at approximately $2.6 billion equity value. Longboard Pharmaceuticals shares jumped 46.8% to $57.13 in the pre-market ...
(RTTNews) - Shares of Longboard Pharmaceuticals, Inc. (LBPH) were surging more than 50 percent in pre-market on Monday on the news of it being acquired by H. Lundbeck A/S in a transaction valued about ...
Longboard Pharmaceuticals (LBPH) on Monday agreed to be acquired by Danish pharmaceutical company H. Lundbeck in a deal with an equity value of about $2.6 billion. Lundbeck will launch a tender offer ...